Dr. Brentnall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4477Fax+1 206-598-4303
Summary
- I am a board certified GI doctor who specializes in the early detection of GI cancers of high-risk individuals. I see high-risk patients in a multi-disciplinary clinic and provide global recommendation for endoscopic surveillance, genetics evaluation, and cancer prevention.
Education & Training
- University of WashingtonFellowship, Gastroenterology, 1991 - 1994
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1987 - 1990
- University of Washington School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1988 - Present
- WA State Medical License 1991 - 2026
Publications & Presentations
PubMed
- 3 citationsDetection of microplastics in human tissues and organs: A scoping review.Nur Sakinah Roslan, Yeong Yeh Lee, Yusof Shuaib Ibrahim, Sabiqah Tuan Anuar, Ku Mohd Kalkausar Ku Yusof
Journal of Global Health. 2024-08-23 - 1 citationsFamilial pancreatic cancer: a long fruitful journey.Teresa A Brentnall
Familial Cancer. 2024-08-01 - 1 citationsThe Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.George Zogopoulos, Ido Haimi, Shenin A Sanoba, Jessica N Everett, Yifan Wang
Journal of the National Comprehensive Cancer Network. 2024-04-01
Grant Support
- Aberrant Glycosylation Signature In Pancreatic CancerNational Cancer Institute2011–2012
- Development Of Chronic Pancreatitis BiomarkersNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Pancreatic Cancer Protein Biomarkers For Early DetectionNational Cancer Institute2006–2010
- Biomarkers Of UC TumorigenesisNational Cancer Institute2006–2010
- Histologic And Molecular Changes In UC TumorigenesisNational Cancer Institute2000–2004
- Oxidative DNA Damage In Ulcerative Colitis TumorigenesisNational Cancer Institute1998–2002
- Predicting Progression To Dysplasia--Ulcerative ColitisNational Cancer Institute1995–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: